Search Results - "INNOCENTI, Gregory"

Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma by Gu, Ting-Lei, Deng, Xiaxing, Huang, Feizhou, Tucker, Meghan, Crosby, Katherine, Rimkunas, Victoria, Wang, Yi, Deng, Gang, Zhu, Lei, Tan, Zhiping, Hu, Yerong, Wu, Chunlin, Nardone, Julie, MacNeill, Joan, Ren, Jianmin, Reeves, Cynthia, Innocenti, Gregory, Norris, Brett, Yuan, Jin, Yu, Jian, Haack, Herbert, Shen, Baiyong, Peng, Chenghong, Li, Hongwei, Zhou, Xinmin, Liu, Xunyang, Rush, John, Comb, Michael J

“…Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary hepatic carcinoma with a median survival of less than 2 years. The…”
Get full text

Signaling networks assembled by oncogenic EGFR and c-Met by Guo, Ailan, Villén, Judit, Kornhauser, Jon, Lee, Kimberly A, Stokes, Matthew P, Rikova, Klarisa, Possemato, Anthony, Nardone, Julie, Innocenti, Gregory, Wetzel, Randall, Wang, Yi, MacNeill, Joan, Mitchell, Jeffrey, Gygi, Steven P, Rush, John, Polakiewicz, Roberto D, Comb, Michael J

“…A major question regarding the sensitivity of solid tumors to targeted kinase inhibitors is why some tumors respond and others do not. The observation that…”
Get full text

Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer by HONG REN, TAN, Zhi-Ping, YI ZHANG, ZHOU, Xin-Min, GU, Ting-Lei, YANG, Yi-Feng, COMB, Michael J, XIN ZHU, CROSBY, Katherine, HAACK, Herbert, REN, Jian-Min, BEAUSOLEIL, Sean, MORITZ, Albrecht, INNOCENTI, Gregory, RUSH, John

“…Ovarian cancer is the leading cause of death from gynecologic cancer. Improvement in the clinical outcome of patients is likely to be achieved by the…”
Get full text

Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer by JIAN YU, KANE, Susan, FERRANTE, Michelle, WAN CHEUNG CHEUNG, XIQIANG HONG, CHIRIEAC, Lucian R, SHOLL, Lynette M, HAACK, Herbert, SMITH, Bradley L, POLAKIEWICZ, Roberto D, YI TAN, GU, Ting-Lei, JIONG WU, LODA, Massimo, XINMIN ZHOU, COMB, Michael J, BENEDETTINI, Elisa, DAIQIANG LI, REEVES, Cynthia, INNOCENTI, Gregory, WETZEL, Randy, CROSBY, Katherine, BECKER, Alison

“…Purpose: Activating mutations within the tyrosine kinase domain of epidermal growth factor receptor (EGFR) are found in approximately 10% to 20% of…”
Get full text

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential by Lohmueller, Jason J., Sato, Shuji, Popova, Lana, Chu, Isabel M., Tucker, Meghan A., Barberena, Roberto, Innocenti, Gregory M., Cudic, Mare, Ham, James D., Cheung, Wan Cheung, Polakiewicz, Roberto D., Finn, Olivera J.

“…MUC1 is a shared tumor antigen expressed on >80% of human cancers. We completed the first prophylactic cancer vaccine clinical trial based on a non-viral…”
Get full text

Human anti-MUC1 antibodies elicited by a prophylactic cancer vaccine for CAR T cell immunotherapy by Lomueller, Jason Jakob, Sato, Shuji, Popova, Lana, Chu, Isabel M, Tucker, Meghan A, Barberena, Roberto, Innocenti, Gregory M, Cudic, Mare, Ham, James D, Cheung, Wan Cheung, Polakiewicz, Roberto D, Finn, Olivera J

“…Abstract Hypoglycosylated MUC1 is a tumor-associated protein that is expressed on over 80% of all human cancers including adenocarcinomas of the colon,…”
Get full text